| [October 31, 2017] |
 |
Alnylam to Webcast Presentations at Upcoming November Investor Conferences
Alnylam
Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics
company, announced today that management will present company overviews
at the following conferences:
-
26th Annual Credit Suisse Healthcare Conference on
Wednesday, November 8, 2017 at 8:40 am MT (10:40 am ET) at the
Phoenician Hotel in Scottsdale, Arizona
-
29th Annual Piper Jaffray Healthcare Conference on
Wednesday, November 29, 2017 at 8:30 am ET at the Lotte New York
Palace Hotel in New York City
-
Evercore ISI (News - Alert) BioPharma Catalyst/Deep Dive Conference on Wednesday,
November 29, 2017 at 9:30 am ET at the Boston Harbor Hotel in Boston
A live audio webcast of each presentation will be available on the
Investors section of the Company's website, www.alnylam.com.
A replay will be available on the Alnylam website within 48 hours after
each event.
About Alnylam Pharmaceuticals
Alnylam (Nasdaq: ALNY) is
leading the translation of RNA interference (RNAi) into a whole new
class of innovative medicines with the potential to transform the lives
of people afflicted with rare genetic, cardio-metabolic, and hepatic
infectious diseases. Based on Nobel (News - Alert) Prize-winning science, RNAi
therapeutics represent a powerful, clinically validated approach for the
treatment of a wide range of severe and debilitating diseases. Founded
in 2002, Alnylam is delivering on a bold vision to turn scientific
possibility into reality, with a robust discovery platform and deep
pipeline of investigational medicines, including four product candidates
that are in late-stage development. Looking forward, Alnylam will
continue to execute on its "Alnylam 2020" strategy of building a
multi-product, commercial-stage biopharmaceutical company with a
sustainable pipeline of RNAi-based medicines to address the needs of
patients who have limited or inadequate treatment options. Alnylam
employs over 600 people in the U.S. and Europe and is headquartered in
Cambridge, MA. For more information about our people, science and
pipeline, please visit www.alnylam.com
and engage with us on Twitter (News - Alert) at @Alnylam
or on LinkedIn.
View source version on businesswire.com: http://www.businesswire.com/news/home/20171031006157/en/
[ Back To TMCnet.com's Homepage ]
|
